Seeking Alpha

Shares of InterMune (ITMN -12.5%) add to yesterday's selloff after the Institute for Quality and...

Shares of InterMune (ITMN -12.5%) add to yesterday's selloff after the Institute for Quality and Efficiency in Health Care concluded that no additional benefit could be found for its idiopathic pulmonary fibrosis drug Esbriet, also known as pirfenidone.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|